dismiss

Visit DOTmed, Booth 1513, at FIME 2015 in Miami / See our Exhibitor Preview here!

SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

EHR vendors and hospitals lagging on interoperability: report Health care organizations have a 'monetary interest' in keeping data

Kickback scheme earns Chicago hospital CEO 4.5 years behind bars 12 years and $35 million in Medicare / Medicaid referrals

Legionnaires' outbreak in New York's South Bronx continues Since July 10 there have been 46 cases, two deaths

Yes, heavy cell phone usage increases risk of brain tumors Researchers identify RFR-induced 'oxidative stress' as the culprit

CMS report on medical homes finds no evidence of cost savings Concluding they don't work, however, 'a mistake'

UK researchers determine five types of prostate cancer Some are 'tigers', others are 'pussycats' — knowing which is which could save lives

Music festival takes aim at regional heroin epidemic In New Jersey, drug addiction does not rock

Leidos, Cerner, Accenture, win highly sought Department of Defense EHR contract Military Health System contract worth at least $4.3 billion

Pantheon acquires IBSL, expands into biomedical service segment Will significantly increase footprint in Italian market

Strength in numbers: The microbiome versus 'superbugs' New insight into how bacteria fight invasion could inform probiotic development

IBA spin-off, Novation ink PET radiopharmaceutical deal

by Brendon Nafziger , DOTmed News Associate Editor
Ion Beam Applications S.A.'s newly spun-off radiopharmaceutical wing IBA Molecular has inked a five-year deal with group purchasing organization Novation LLC to supply its member health care facilities with PET radiotracers.

Under the deal, announced Monday, IBA Molecular will supply imaging agents, including 18-Fluorodeoxyglucose, as well as provide educational and training services. The contract took effect July 1. Terms of the deal weren't disclosed.

Story Continues Below Advertisement

Joint Commission changes are here! Are YOU ready?

As the leading Joint Commission accreditation service provider in the U.S., WEST PHYSICS knows these new requirements in depth. Click here to find out how WEST PHYSICS can help guide you successfully through the process.



IBA Molecular has 54 PET isotope facilities in Europe, North America and Asia. It also delivers agents for SPECT imaging worldwide.

SK Capital Partners holds a controlling stake in IBA Molecular, which was spun off from its Belgian parent company, which retains a minority stake, in April.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED